Paraquat and iron exposure as possible synergistic environmental risk factors in Parkinson’s disease
The DOI matches its Crossref record; 88 of the 89 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“its toxicity may be expected to be exacerbated by iron, and this is the case”
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914 · cited 1×
“This hypothesis is in keeping with the discovery in the 1980s of an environmental synthetic heroin analogue, 1-methyl-4-phenyl-1,2,3,6tetrahydropyridine (MPTP), which has been demonstrated to cause a parkinsonian syndrome following inadvertent exposure in drug addicts which clinically, biochemically, and pathologicall…”
ResultAlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836 · cited 1×
“Changes in the amino acid sequence of the α-synuclein protein in rare autosomal dominant familial forms of PD are capable of resulting in neurodegeneration and Lewy body formation along with clinical symptoms of the disease (Polymeropoulos et al., 1997; Kruger et al., 1998 ).”
BackgroundSpillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868 · cited 1×
“Lewy bodies represent a major pathological hallmark of PD (Spillantini et al., 1997; Baba et al., 1998; Spillantini et al., 1998 ).”
BackgroundA Drosophila model of Parkinson's disease
Feany, M. B., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,118
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765 · cited 1×
“Transgenic fly and mouse models of in vivo α-synuclein overexpression in the brain, which enhance aggregation of the protein, are associated with neurotoxicity (Feany and Bender 2000; Masliah et al., 2000 ).”
Background(1998) · Europe PMC (PubMed Central) · Cited by 1,594
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease
Dexter, D. T., Carter, C. J., Wells, F. R., Javoy‐Agid, F., Agid, Y., Lees, A., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397 · cited 1×
“Iron levels in the SN have been reported to be elevated in PD patients ( Dexter et al., 1989; Dexter et al., 1990; Sofic et al., 1991; Ben-Shachar and Youdim 1993; Jellinger et al., 1993; Youdim et al., 1993).”
BackgroundTransition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383 · cited 1×
“This may be exacerbated in the Parkinsonian brain where early depletion in SN levels of the peroxidereducing agent glutathione (GSH) have been reported (Perry et al., 1982; Riederer et al., 1989; Jenner, 1993).”
BackgroundMetal-triggered Structural Transformations, Aggregation, and Fibrillation of Human α-Synuclein
Uversky, V. N., Li, J., & Fink, A. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105343200 · Cited by 1,103 · cited 1×
“Findings from several laboratories have suggested that exposure to pesticides or metals alone enhances α-synuclein aggregation in vitro in a dose-dependent fashion likely via an oxidative stress-mediated mechanism (e.g., Hashimoto et al., 1999; Paik et al., 1999; Hsu et al., 2000; Ostrerova-Golts et al., 2000; Uversky…”
BackgroundBeal, M. F. (1992) · Annals of Neurology · doi:10.1002/ana.410310202 · Cited by 961 · cited 2×
“nucleic acids, and membrane phospholipids leading to cellular degeneration ( Beal, 1992; Gutteridge, 1992).”
BackgroundThe oxidant stress hypothesis in Parkinson's disease: Evidence supporting it
Fahn, S., & Cohen, G. (1992) · Annals of Neurology · doi:10.1002/ana.410320616 · Cited by 927 · cited 1×
“Dopaminergic neurons of the nigrostriatal system have long been proposed to be selectively prone to oxidative damage due to the combined presence of both dopamine and iron (Beal, 1992; Fahn and Cohen, 1992; Hirsch, 1992).”
BackgroundParkinson Disease in Twins: An Etiologic Study
Tanner, C. M., Ottman, R., Goldman, S. M., Ellenberg, J., Chan, P., Mayeux, R., & Langston, J. W. (1999) · JAMA · doi:10.1001/jama.281.4.341 · Cited by 867 · cited 1×
“Epidemiological evidence from an extensive twin study (19,000 caucasian males) indicated that idiopathic Parkinson's disease (PD) in individuals with an age of onset after the age of 50 was not likely explainable by genetic heritability ( Tanner et al., 1999 ).”
BackgroundMcCormack, A. L., Thiruchelvam, M., Manning-Bog, A. B., Thiffault, C., Langston, J. W., Cory-Slechta, D. A., & Di Monte, D. A. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0507 · Cited by 838 · cited 3×
“Indeed, recent work by DiMonte's group has reported that toxicity is selective for dopaminergic neurons of the SN ( McCormack et al., 2002; see below).”
BackgroundInfluentialParkinson's disease: A disorder due to nigral glutathione deficiency?
Perry, T. L., Godin, D. V., & Hansen, S. (1982) · Neuroscience Letters · doi:10.1016/0304-3940(82)90390-1 · Cited by 753 · cited 1×
“This may be exacerbated in the Parkinsonian brain where early depletion in SN levels of the peroxidereducing agent glutathione (GSH) have been reported ( Perry et al., 1982; Riederer et al., 1989; Jenner, 1993).”
Backgroundα-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress
Hsu, L. J., Sagara, Y., Arroyo, A., Rockenstein, E., Sisk, A., Mallory, M., Wong, J., Takenouchi, T., Hashimoto, M., & Masliah, E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64553-1 · Cited by 714 · cited 1×
“Findings from several laboratories have suggested that exposure to pesticides or metals alone enhances α-synuclein aggregation in vitro in a dose-dependent fashion likely via an oxidative stress-mediated mechanism (e.g., Hashimoto et al., 1999; Paik et al., 1999; Hsu et al., 2000; Ostrerova-Golts et al., 2000; Uversky…”
BackgroundUnderstanding cell death in parkinson's disease
Jenner, P., & Olanow, C. W. (1998) · Annals of Neurology · doi:10.1002/ana.410440712 · Cited by 685
The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice
Manning-Bog, A. B., McCormack, A. L., Li, J., Uversky, V. N., Fink, A. L., & Di Monte, D. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100560200 · Cited by 684
The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living
Gorell, J. M., Johnson, C. C., Rybicki, B. A., Peterson, E. L., & Richardson, R. J. (1998) · Neurology · doi:10.1212/wnl.50.5.1346 · Cited by 639
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620
Self-citationEnvironmental risk factors and Parkinson's disease: A case‐control study in Taiwan
Liou, H. H., Tsai, M. C., Chen, C. J., Jeng, J. S., Chang, Y. C., Chen, S. Y., & Chen, R. C. (1997) · Neurology · doi:10.1212/wnl.48.6.1583 · Cited by 616
Paraquat: model for oxidant-initiated toxicity.
Bus, J. S., & Gibson, J. E. (1984) · Environmental Health Perspectives · doi:10.1289/ehp.845537 · Cited by 593
Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains
Sofic, E., Paulus, W., Jellinger, K., Riederer, P., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02017.x · Cited by 524 · cited 1×
“Iron levels in the SN have been reported to be elevated in PD patients (Dexter et al., 1989; Dexter et al., 1990; Sofic et al., 1991; Ben-Shachar and Youdim 1993; Jellinger et al., 1993; Youdim et al., 1993).”
BackgroundPrzedborski, S., Jackson‐Lewis, V., Naini, A. B., Jakowec, M., Petzinger, G., Miller, R., & Akram, M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00183.x · Cited by 507
The A53T α-Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity
Ostrerova-Golts, N., Petrucelli, L., Hardy, J., Lee, J. M., Farer, M., & Wolozin, B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06048.2000 · Cited by 466 · cited 1×
“Findings from several laboratories have suggested that exposure to pesticides or metals alone enhances α-synuclein aggregation in vitro in a dose-dependent fashion likely via an oxidative stress-mediated mechanism (e.g., Hashimoto et al., 1999; Paik et al., 1999; Hsu et al., 2000; Ostrerova-Golts et al., 2000; Uversky…”
BackgroundParkinson's disease and exposure to agricultural work and pesticide chemicals
Semchuk, K. M., Love, E. J., & Lee, R. G. (1992) · Neurology · doi:10.1212/wnl.42.7.1328 · Cited by 439
Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss
Brooks, A. I., Chadwick, C. A., Gelbard, H. A., Cory-Slechta, D. A., & Federoff, H. J. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01192-5 · Cited by 424 · cited 2×
“These results corroborate those of an earlier study in which systemic PQ administration in mice was reported to result in decreased SN dopamine neuron and striatal neurite numbers and reduced ambulatory movement similar to that observed following systemic MPTP administration ( Brooks et al., 1999 ).”
BackgroundResultPerry, T. L., & Yong, V. W. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90320-4 · Cited by 361 · cited 1×
“The role of PQ exposure in PD development has been an area of controversy due to lack, until recently, of unequivocal demonstration of dopaminergic SN toxicity following systemic exposure of animals (Koller 1986; Perry and Yong 1986; Liou et al., 1996; Widdowson et al., 1996a; Widdowson et al., 1996b; Brooks et al., 1…”
BackgroundUversky, V. N., Li, J., & Fink, A. L. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02597-2 · Cited by 350 · cited 1×
“It has recently been demonstrated that the iron-enhanced formation of α-synuclein fibrils may be due to direct alterations in secondary structure leading to a partially-folded intermediate that is more susceptible to aggregation ( Uversky et al., 2001b ).”
BackgroundCopper(II)-induced self-oligomerization of α-synuclein
Paik, S. R., Shin, H.-J., Lee, J., Chang, C., & Kim, J. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3400821 · Cited by 337
Thiruchelvam, M., Brockel, B. J., Richfield, E. K., Baggs, R. B., & Cory-Slechta, D. A. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02496-3 · Cited by 324 · cited 2×
“Others have reported that PQ alone may have no toxic effects, but most of these studies relied on examining only striatal dopamine levels and did not assess numbers of TH+ SN neurons (Perry et al., 1986; Thiruchelvam et al., 2000 ).”
BackgroundResultThe possible role of iron in the etiopathology of parkinson's disease
Youdim, M. B. H., Ben‐Shachar, D., & Riederer, P. (1993) · Movement Disorders · doi:10.1002/mds.870080102 · Cited by 301
Trojanowski, J. Q., Goedert, M., Iwatsubo, T., & Lee, V. M.-Y. (1998) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400432 · Cited by 297 · cited 1×
“Selfaggregation of α-synuclein has been suggested to be responsible for the formation and deposition of insoluble aggregates which could ultimately play a role in subsequent neurogeneration (Trojanowski and Lee 1998; Trojanowski et al., 1998 ).”
BackgroundParkinson's disease: A case‐control study of occupational and environmental risk factors
Hertzman, C., Wiens, M., Bowering, D., Snow, B., & Calne, D. (1990) · American Journal of Industrial Medicine · doi:10.1002/ajim.4700170307 · Cited by 290 · cited 2×
“The widely used herbicide 1,1'-dimethyl-4,4'-bipyridium (paraquat, PQ) has been suggested as a prime candidate based both on reports of parkinsonism correlated with exposure to the agent ( Hertzman et al., 1990; Liou et al., 1997) and its structural similarity to the active metabolite of MPTP, 1-methyl-4-phenylpyridiu…”
BackgroundRisk factors for Parkinson's disease
Hubble, J. P., Cao, T., Hassanein, R. E. S., Neuberger, J. S., & Roller, W. C. (1993) · Neurology · doi:10.1212/wnl.43.9.1693 · Cited by 275
Sequestration of iron by Lewy bodies in Parkinson's disease
Castellani, R. J., Siedlak, S. L., Perry, G., & Smith, M. A. (2000) · Acta Neuropathologica · doi:10.1007/s004010050001 · Cited by 265 · cited 1×
“Iron has recently been identified as a component of Lewy bodies of the SN( Castellani et al., 2000 ).”
BackgroundNeuropathology of synuclein aggregates: New insights into mechanisms of neurodegenerative diseases
Duda, J. E., Lee, V. M.-Y., & Trojanowski, J. Q. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000715)61:2<121::aid-jnr1>3.0.co;2-4 · Cited by 264
Carrier-mediated processes in blood–brain barrier penetration and neural uptake of paraquat
Shimizu, K., Ohtaki, K., Matsubara, K., Aoyama, K., Uezono, T., Saito, O., Suno, M., Ogawa, K., Hayase, N., Kimura, K., et al. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02577-x · Cited by 263 · cited 1×
“PQ has been shown not only to be capable of crossing the BBB but also appears to result in adverse effects on the dopaminergic nigrostriatal system (Widdowson et al., 1996b; Corasaniti et al., 1998; Shimizu et al., 2001 ).”
BackgroundDecreased ferritin levels in brain in Parkinson's disease
Dexter, D. T., Carayon, A., Vidailhet, M., Ruberg, M., Agid, F., Agid, Y., Lees, A. J., Wells, F. R., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08814.x · Cited by 258 · cited 1×
“Iron levels in the SN have been reported to be elevated in PD patients (Dexter et al., 1989; Dexter et al., 1990; Sofic et al., 1991; Ben-Shachar and Youdim 1993; Jellinger et al., 1993; Youdim et al., 1993).”
Background. Chun, H. S., Gibson, G. E., DeGiorgio, L. A., Zhang, H., Kidd, V. J., & Son, J. H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00096.x · Cited by 256
Trojanowski, J. Q., & Lee, V. M.-Y. (1998) · Archives of Neurology · doi:10.1001/archneur.55.2.151 · Cited by 254 · cited 1×
“Selfaggregation of α-synuclein has been suggested to be responsible for the formation and deposition of insoluble aggregates which could ultimately play a role in subsequent neurogeneration ( Trojanowski and Lee 1998; Trojanowski et al., 1998).”
BackgroundFall, P.-A., Fredrikson, M., Axelson, O., & Gran�rus, A.-K. (1999) · Movement Disorders · doi:10.1002/1531-8257(199901)14:1<28::aid-mds1007>3.0.co;2-o · Cited by 244
Role of Cytochrome c as a Stimulator of α-Synuclein Aggregation in Lewy Body Disease
Hashimoto, M., Takeda, A., Hsu, L. J., Takenouchi, T., & Masliah, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.28849 · Cited by 236 · cited 1×
“Findings from several laboratories have suggested that exposure to pesticides or metals alone enhances α-synuclein aggregation in vitro in a dose-dependent fashion likely via an oxidative stress-mediated mechanism (e.g., Hashimoto et al., 1999; Paik et al., 1999; Hsu et al., 2000; Ostrerova-Golts et al., 2000; Uversky…”
BackgroundEffect of the overexpression of wild‐type or mutant α‐synuclein on cell susceptibility to insult
Lee, M., Hyun, D., Halliwell, B., & Jenner, P. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00149.x · Cited by 232
Münch, G., Lüth, H. J., Wong, A., Arendt, T., Hirsch, E., Ravid, R., & Riederer, P. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00096-x · Cited by 231 · cited 1×
“AGEs have been reported to be are markers of ironinduced oxidative stress ( Munch et al., 2000 ).”
Background(2002) · doi:10.1016/s0304-3940(02)00016-2 · Cited by 225
Developmental changes in transferrin and iron uptake by the brain in the rat
Taylor, E. M., & Morgan, E. H. (1990) · Developmental Brain Research · doi:10.1016/0165-3806(90)90103-6 · Cited by 221 · cited 1×
“Although neither increases in dietary iron intake nor prolonged occupational exposure to iron in adults correlate with an increased incidence of PD (Logroscino et al., 1998; Anderson et al., 1999; Gorell et al., 1999) the neonatal period is known to be critical for establishment of normal iron content in the adult bra…”
BackgroundGiasson, B. I., Jakes, R., Goedert, M., Duda, J. E., Leight, S., Trojanowski, J. Q., & Lee, V. M. Y. (2000) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(20000215)59:4<528::aid-jnr8>3.0.co;2-0 · Cited by 218 · cited 1×
“Several reports of oxidative (nitration) damage to α-synuclein in synucleopathies have been published (Duda et al., 2000; Giasson et al., 2000 ) as well as following MPTP administration (Przedborski et al., 2001).”
BackgroundHashimoto, M., Hsu, L. J., Rockenstein, E., Takenouchi, T., Mallory, M., & Masliah, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111428200 · Cited by 205 · cited 1×
“α-Synuclein aggregation may in turn generate additional oxidative stress although there are conflicting reports that suggest that it may also act to protect against oxidative stress (Lee et al., 2001; Hashimoto et al., 2002 ).”
Background1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride Neurotoxicity Is Attenuated in Mice Overexpressing Bcl-2
Yang, L., Matthews, R. T., Schulz, J. B., Klockgether, T., Liao, A. W., Martinou, J.-C., Penney, J. B., Hyman, B. T., & Beal, M. F. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08145.1998 · Cited by 199
Iron and oxygen radicals in brain
Gutteridge, J. M. C. (1992) · Annals of Neurology · doi:10.1002/ana.410320705 · Cited by 190 · cited 1×
“nucleic acids, and membrane phospholipids leading to cellular degeneration (Beal, 1992; Gutteridge, 1992 ).”
BackgroundNormal deposition of brain iron in childhood and adolescence: MR imaging at 1.5 T.
Aoki, S., Okada, Y., Nishimura, K., Barkovich, A. J., Kjos, B. O., Brasch, R. C., & Norman, D. (1989) · Radiology · doi:10.1148/radiology.172.2.2748819 · Cited by 174
Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease
Jenner, P. (1993) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb00013.x · Cited by 163
Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice
Lan, J., & Jiang, D. H. (1997) · Journal of Neural Transmission · doi:10.1007/bf01277665 · Cited by 159 · cited 1×
“Conversely, treatment with the iron chelator desferrioxamine appears to inhibit the iron accumulation, elevation in ROS levels, GSH depletion, and loss of striatal dopamine associated with MPTP administration ( Lan and Jiang 1997a ).”
BackgroundTransferrin and Iron Uptake by the Brain: Effects of Altered Iron Status
Taylor, E. M., Crowe, A., & Morgan, E. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb06355.x · Cited by 149 · cited 1×
“Although neither increases in dietary iron intake nor prolonged occupational exposure to iron in adults correlate with an increased incidence of PD (Logroscino et al., 1998; Anderson et al., 1999; Gorell et al., 1999) the neonatal period is known to be critical for establishment of normal iron content in the adult bra…”
BackgroundOccupational Metal Exposures and the Risk of Parkinson’s Disease
Gorell, J. M., Rybicki, B. A., Cole Johnson, C., & Peterson, E. L. (1999) · Neuroepidemiology · doi:10.1159/000026225 · Cited by 146 · cited 1×
“Although neither increases in dietary iron intake nor prolonged occupational exposure to iron in adults correlate with an increased incidence of PD (Logroscino et al., 1998; Anderson et al., 1999; Gorell et al., 1999 ) the neonatal period is known to be critical for establishment of normal iron content in the adult br…”
BackgroundEffects of l‐dopa and other amino acids against paraquat‐induced nigrostriatal degeneration
McCormack, A. L., & Di Monte, D. A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01621.x · Cited by 130
Evidence for neuromelanin involvement in MPTP-induced neurotoxicity
D’Amato, R. J., Alexander, G. M., Schwartzman, R. J., Kitt, C. A., Price, D. L., & Snyder, S. H. (1987) · Nature · doi:10.1038/327324a0 · Cited by 127
Occupational Metal Exposures and the Risk of Parkinson’s Disease
Raterman, K. (2011) · Cited by 124
Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease?
Hirsch, E. C. (1992) · Annals of Neurology · doi:10.1002/ana.410320715 · Cited by 123 · cited 1×
“Dopaminergic neurons of the nigrostriatal system have long been proposed to be selectively prone to oxidative damage due to the combined presence of both dopamine and iron (Beal, 1992; Fahn and Cohen, 1992; Hirsch, 1992 ).”
BackgroundLan, J., & Jiang, D. (1997) · Journal of Neural Transmission · doi:10.1007/bf01291883 · Cited by 106 · cited 1×
“1985) and to result in significantly higher levels of both lipid peroxidation and dopaminergic cell loss following MPTP administration in vivo -- suggesting that elevated iron can contribute to the toxicity of the compound ( Lan and Jiang 1997b ).”
BackgroundLiou, H., Chen, R.-C., Tsai, Y.-F., Chen, W., Chang, Y.-C., & Tsai, M.-C. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0054 · Cited by 105 · cited 1×
“The role of PQ exposure in PD development has been an area of controversy due to lack, until recently, of unequivocal demonstration of dopaminergic SN toxicity following systemic exposure of animals (Koller 1986; Perry and Yong 1986; Liou et al., 1996; Widdowson et al., 1996a; Widdowson et al., 1996b; Brooks et al., 1…”
BackgroundPoirier, J., Donaldson, J., & Barbeau, A. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)91639-0 · Cited by 101
Clejan, L. A., & Cederbaum, A. I. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90412-7 · Cited by 90 · cited 1×
“PQ generates superoxide both through electron transfer reactions with NADHdependent oxireductases and by redox cycling via reaction with molecular oxygen (Bus and Gibson, 1984; Clejan and Cederbaum, 1989; Burkitt et al., 1993; Kadiiska et al., 1993; Shimada et al., 1998; Yang and Sun, 1998).”
BackgroundShimada, H., Hirai, K., Simamura, E., & Pan, J. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0557 · Cited by 88 · cited 1×
“PQ generates superoxide both through electron transfer reactions with NADHdependent oxireductases and by redox cycling via reaction with molecular oxygen (Bus and Gibson, 1984; Clejan and Cederbaum, 1989; Burkitt et al., 1993; Kadiiska et al., 1993; Shimada et al., 1998; Yang and Sun, 1998).”
BackgroundSelective vulnerability of pigmented dopaminergic neurons in Parkinson's disease
Hirsch, E. C., Graybiel, A. M., & Agid, Y. (1989) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1989.tb01778.x · Cited by 85
Iron and ferritin in substantia nigra in Parkinson's disease.
Jellinger, K. A., Kienzl, E., Rumpelmaier, G., Paulus, W., Riederer, P., Stachelberger, H., Youdim, M. B. H., & Ben‐Shachar, D. (1993) · PubMed · Cited by 78
(1998) · PubMed · Cited by 74
Paraquat: A Useful Tool for the in vivo Study of Mechanisms of Neuronal Cell Death
Corasaniti, M. T., Strongoli, M. C., Rotiroti, D., Bagetta, G., & Nisticò, G. (1998) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1998.tb01434.x · Cited by 73
Jiménez‐Jiménez, F. J., Mateo, D., & Giménez-Roldán, S. (1992) · Movement Disorders · doi:10.1002/mds.870070209 · Cited by 72
Fredriksson, A., Fredriksson, M., & Eriksson, P. O. (1993) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1993.1194 · Cited by 72
Jha, N., Kumar, M. J., Boonplueang, R., & Andersen, J. K. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00009.x · Cited by 63 · cited 1×
“This may in turn result in subsequent protein-buildup ( Jha et al., 2002 ).”
BackgroundSelf-citationSchneider, J. S., & Denaro, F. (1988) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198807000-00006 · Cited by 59 · cited 1×
“The widely used herbicide 1,1'-dimethyl-4,4'-bipyridium (paraquat, PQ) has been suggested as a prime candidate based both on reports of parkinsonism correlated with exposure to the agent (Hertzman et al., 1990; Liou et al., 1997) and its structural similarity to the active metabolite of MPTP, 1-methyl-4-phenylpyridium…”
BackgroundPerry, T. L., Yong, V. W., Wall, R. A., & Jones, K. L. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90495-7 · Cited by 58 · cited 1×
“Others have reported that PQ alone may have no toxic effects, but most of these studies relied on examining only striatal dopamine levels and did not assess numbers of TH+ SN neurons ( Perry et al., 1986; Thiruchelvam et al., 2000).”
ResultIron, melanin and dopamine interaction: relevance to parkinson's disease
Ben‐Shachar, D., & Youdim, M. B. H. (1993) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(93)90038-t · Cited by 57 · cited 1×
“Iron levels in the SN have been reported to be elevated in PD patients (Dexter et al., 1989; Dexter et al., 1990; Sofic et al., 1991; Ben-Shachar and Youdim 1993; Jellinger et al., 1993; Youdim et al., 1993).”
BackgroundParaquat and Parkinson's disease
Koller, W. C. (1986) · Neurology · doi:10.1212/wnl.36.8.1147-b · Cited by 57
Widdowson, P. S., Farnworth, M. J., Upton, R., & Simpson, M. (1996) · Human & Experimental Toxicology · doi:10.1177/096032719601500706 · Cited by 54 · cited 2×
“The role of PQ exposure in PD development has been an area of controversy due to lack, until recently, of unequivocal demonstration of dopaminergic SN toxicity following systemic exposure of animals (Koller 1986; Perry and Yong 1986; Liou et al., 1996; Widdowson et al., 1996a; Widdowson et al., 1996b; Brooks et al., 1…”
BackgroundBurkitt, M. J., Kadiiska, M. B., Hanna, P. M., Jordan, S. J., & Mason, R. P. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13607-9 · Cited by 54
Widdowson, P., Farnworth, M., Simpson, M., & Lock, E. (1996) · Human & Experimental Toxicology · doi:10.1177/096032719601500308 · Cited by 50 · cited 1×
“The role of PQ exposure in PD development has been an area of controversy due to lack, until recently, of unequivocal demonstration of dopaminergic SN toxicity following systemic exposure of animals (Koller 1986; Perry and Yong 1986; Liou et al., 1996; Widdowson et al., 1996a; Widdowson et al., 1996b; Brooks et al., 1…”
BackgroundParaquat-Induced Free Radical Reaction in Mouse Brain Microsomes
Yang, W., & Sun, A. Y. (1998) · Neurochemical Research · doi:10.1023/a:1022497319548 · Cited by 48 · cited 2×
“PQ generates superoxide both through electron transfer reactions with NADHdependent oxireductases and by redox cycling via reaction with molecular oxygen (Bus and Gibson, 1984; Clejan and Cederbaum, 1989; Burkitt et al., 1993; Kadiiska et al., 1993; Shimada et al., 1998; Yang and Sun, 1998 ).”
BackgroundThe geographic distribution of Parkinson's disease mortality in the United States
Lanska, D. J. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)05371-9 · Cited by 47
Liou, H., Chen, R.-C., Chen, T. H.-H., Tsai, Y., & Tsai, M.-C. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9130 · Cited by 38 · cited 1×
“Intranigral administration of PQ in rats has also been reported to result in a dose-dependent depletion in striatal dopamine levels, resulting in contralateral apomorphine-induced rotational behavior ( Liou et al., 2001 ).”
BackgroundExposure to Home Pesticides Linked to Parkinson Disease
Stephenson, J. (2000) · JAMA · doi:10.1001/jama.283.23.3055 · Cited by 31 · cited 1×
“... postulated to be a potential environmental risk factor for the disease and this hypothesis is supported by extensive epidemiological evidence suggesting increased PD incidence in persons living in a rural environment, drinking well water, and experiencing occupational exposure to these types of agents (Hertzman et…”
BackgroundKadiiska, M. B., Hanna, P. M., & Mason, R. P. (1993) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1993.1236 · Cited by 29
Gerlach, M., Desser, H., Youdim, M. B. H., & Riederer, P. F. (1996) · Springer eBooks · doi:10.1007/978-3-7091-7494-4_2 · Cited by 24
Geographical variations in mortality from Parkinson's disease in Japan, 1977-1985
Imaizumi, Y. (1995) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1995.tb07013.x · Cited by 16 · cited 1×
“This along with variations in incidence of PD by geographic region suggests that sporadic late onset PD may be due to environmental factors perhaps in combination with genetic susceptibility ( Imaizumi 1995; Lanska 1997; Liou et al., 1997).”
Background(1998) · Movement Disorders · doi:10.1002/mds.870130102 · Cited by 16
Research works printed but not linked: 1
- Anderson, C, H Checkoway, GM Franklin, S Beresford, T Smith-Weller and PD Swanson (1999) Dietary factors in Parkinson's disease: the role of food groups and specific foods.Mov. Disord. 14, 21–27. · DOI · Paper page
Cited by
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“As such, its toxicity may be expected to be exacerbated by iron, and this is the case (Andersen 2003; Ayaki et al. 2005; Fernandez et al. 2000; Peng et al. 2007, 2009).”
BackgroundMolecular mechanisms of pesticide-induced neurotoxicity: Relevance to Parkinson's disease
Franco, R., Li, S., Rodriguez-Rocha, H., Burns, M., & Panayiotidis, M. I. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.06.003 · Cited by 257
“[2,3,5,8,14,31,32].”
BackgroundGenetic mouse models of Parkinson’s disease
Magen, I., & Chesselet, M. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)84004-x · Cited by 156
“As long-term exposure to the pesticide para quat constitutes possible risk factors for sporadic PD (Andersen, 2003), paraquat was adminis tered to mice overexpressing human WT a-syn”
BackgroundYang, W., & Tiffany‐Castiglioni, E. (2005) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390500226987 · Cited by 122
Paraquat-Induced Apoptosis in Human Neuroblastoma SH-SY5Y Cells: Involvement of p53 and Mitochondria
Yang, W., & Tiffany‐Castiglioni, E. (2008) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390701738467 · Cited by 100
“Therefore, paraquat is under investigation as an environmental risk and etiologic factor in PD occurrence (Andersen, 2003; Di Monte, 2003).”
Background
Metadata
- Authors
- Andersen, J. K.
- Affiliations
- Buck Institute for Research on Aging (US)
- Corresponding author
- Andersen, Julie K.
- ORCID
- Andersen, Julie K.
- Venue
- Neurotoxicity Research
- Published
- 2003-01
- Volume
- 5
- Issue
- 5
- Pages
- 307-313
- ISSN
- 1029-8428 (ISSN-L)
- 1476-3524
- OpenAlex
- W1988814315
- Cited by
- 40
- References
- 89
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 1 · 2018: 2 · 2017: 1 · 2014: 2 · 2013: 1
- FWCI
- 0.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neurotoxicity Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pesticide Exposure and Toxicity
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Heavy Metal Exposure and Toxicity
- Keywords
- paraquat, iron exposure, Parkinson's disease, synergistic risk factors, environmental risk factors, neurotoxicity
- MeSH terms
- Dopamine, Drug Synergism, Environmental Pollutants, Herbicides, Humans, Iron, Nerve Degeneration, Nerve Tissue Proteins, Paraquat, Parkinson Disease, Secondary, Risk Factors, Synucleins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.